These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6710531)

  • 1. Characterization of the wasting syndrome in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Seefeld MD; Corbett SW; Keesey RE; Peterson RE
    Toxicol Appl Pharmacol; 1984 Apr; 73(2):311-22. PubMed ID: 6710531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digestible energy and efficiency of feed utilization in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Seefeld MD; Peterson RE
    Toxicol Appl Pharmacol; 1984 Jun; 74(2):214-22. PubMed ID: 6740672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of the wasting syndrome to lethality in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Christian BJ; Inhorn SL; Peterson RE
    Toxicol Appl Pharmacol; 1986 Feb; 82(2):239-55. PubMed ID: 3945951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body weight regulation in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Seefeld MD; Keesey RE; Peterson RE
    Toxicol Appl Pharmacol; 1984 Dec; 76(3):526-36. PubMed ID: 6506077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypophagia-induced weight loss in mice, rats, and guinea pigs treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kelling CK; Christian BJ; Inhorn SL; Peterson RE
    Fundam Appl Toxicol; 1985 Aug; 5(4):700-12. PubMed ID: 4043592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma corticosterone levels and histopathology of the adrenals and thymuses in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats.
    Gorski JR; Muzi G; Weber LW; Pereira DW; Iatropoulos MJ; Rozman K
    Toxicology; 1988 Dec; 53(1):19-32. PubMed ID: 3201474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of pharmacological agents given peripherally with respect to TCDD-induced wasting syndrome in Long-Evans rats.
    Pohjanvirta R; Tuomisto J; Vikkula K
    Pharmacol Toxicol; 1988 Oct; 63(4):240-7. PubMed ID: 2973575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of alterations in energy metabolism to hypophagia in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Potter CL; Menahan LA; Peterson RE
    Fundam Appl Toxicol; 1986 Jan; 6(1):89-97. PubMed ID: 3086171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J and DBA/2J mice.
    Chapman DE; Schiller CM
    Toxicol Appl Pharmacol; 1985 Mar; 78(1):147-57. PubMed ID: 4035666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subchronic oral toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the guinea pig: comparisons with a PCB-containing transformer fluid pyrolysate.
    DeCaprio AP; McMartin DN; O'Keefe PW; Rej R; Silkworth JB; Kaminsky LS
    Fundam Appl Toxicol; 1986 Apr; 6(3):454-63. PubMed ID: 3084328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgenic deficiency in male rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Moore RW; Potter CL; Theobald HM; Robinson JA; Peterson RE
    Toxicol Appl Pharmacol; 1985 Jun; 79(1):99-111. PubMed ID: 4049410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormones modulate the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Rozman K; Rozman T; Scheufler E; Pazdernik T; Greim H
    J Toxicol Environ Health; 1985; 16(3-4):481-91. PubMed ID: 4087313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some endocrine and morphological aspects of the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Gorski JR; Muzi G; Weber LW; Pereira DW; Arceo RJ; Iatropoulos MJ; Rozman K
    Toxicol Pathol; 1988; 16(3):313-20. PubMed ID: 3057589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of wasting syndrome and lethality caused by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Rozman K
    Toxicol Lett; 1984 Sep; 22(3):279-85. PubMed ID: 6485001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on plasma and tissue beta-endorphin-like immunoreactivity in the most TCDD-susceptible and the most TCDD-resistant rat strain.
    Pohjanvirta R; Unkila M; Tuomisto JT; Vuolteenaho O; Leppäluoto J; Tuomisto J
    Life Sci; 1993; 53(19):1479-87. PubMed ID: 8412511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thyroidectomy and thyroxine on 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced toxicity.
    Rozman K; Rozman T; Greim H
    Toxicol Appl Pharmacol; 1984 Feb; 72(2):372-6. PubMed ID: 6695381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and evidence for metabolic alterations in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated guinea pigs fed by total parenteral nutrition.
    Huang Lu CJ; Baggs RB; Redmond D; Henry EC; Schecter A; Gasiewicz TA
    Toxicol Appl Pharmacol; 1986 Jul; 84(3):439-53. PubMed ID: 3088772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and fasting on body weight and lipid parameters in rats.
    Schiller CM; Adcock CM; Moore RA; Walden R
    Toxicol Appl Pharmacol; 1985 Nov; 81(2):356-61. PubMed ID: 4060161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothyroxinemia and hypothermia in rats in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin administration.
    Potter CL; Sipes IG; Russell DH
    Toxicol Appl Pharmacol; 1983 Jun; 69(1):89-95. PubMed ID: 6134353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remarkable residual alterations in responses to feeding regulatory challenges in Han/Wistar rats after recovery from the acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
    Pohjanvirta R; Tuomisto J
    Food Chem Toxicol; 1990 Oct; 28(10):677-86. PubMed ID: 2276696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.